MONDAY, April 7, 2014 (HealthDay News) -- Pregnant women at high
risk for the serious condition called preeclampsia should take
low-dose aspirin every day after their first trimester, according
to a new draft recommendation by an influential U.S. panel of
Daily low-dose aspirin (81 milligrams) in middle and late
pregnancy can significantly reduce the occurrence of preeclampsia
among these women. And it can lower the risk of preterm birth or
low birth weight resulting from the pregnancy-related condition,
according to the recommendation by the U.S. Preventive Services
"Preeclampsia is one of the more common causes of serious health problems for both the expectant mother and their baby," said Dr. Michael LeFevre, chairman of the task force, and vice chair of family and community medicine at the University of Missouri School of Medicine. "At least for pregnant women at high risk for preeclampsia, a low dose of aspirin taken daily can help prevent the condition and improve the outcome for both mother and child."
The evidence review upon which the recommendations are based was
published online April 7 in the journal
Annals of Internal Medicine.
Preeclampsia is a complex condition that occurs in pregnant
women and involves an increase in blood pressure and excess protein
in the urine after 20 weeks of pregnancy. About 4 percent of all
pregnancies in the United States are affected by preeclampsia,
according to information from the journal.
It's important to prevent preeclampsia because the only
treatment once it takes hold is delivery, which can pose risks to
the baby if performed before 34 weeks of gestation. Preeclampsia is
responsible for more than one-third of the serious health problems
that occur among pregnant women, and 15 percent of preterm births,
the journal noted.
Pregnant women who contract preeclampsia can suffer potentially
life-threatening organ damage or stroke. Unborn fetuses grow too
slowly as the condition robs them of oxygen and nutrients, leading
to low birth weight babies, preterm birth or stillbirth, the
"The baby grows too slowly, so you get a small baby, or you have to deliver the baby early to save the mother's life because it can lead to stroke," said Jillian Henderson, lead author of the evidence review and an investigator at the Kaiser Permanente Center for Health Research in Portland, Ore.
LeFevre said women at high risk of preeclampsia include those in
the following categories:
A doctor also might recommend daily aspirin use in women who
have a combination of two or more moderate risk factors, LeFevre
said. These include women who are:
Daily low-dose aspirin use reduced the risk of preterm birth by
14 percent and of slow fetal growth by 20 percent, according to the
new review of the latest medical data. And it led to a 24 percent
reduction in the overall occurrence of preeclampsia, the review
In addition, there's no evidence of potential harm in daily
low-dose aspirin use for pregnant women at high risk of
preeclampsia, study author Henderson said.
However, any expectant mother should consult with her doctor
before beginning a daily aspirin regimen, LeFevre added.
"We certainly don't want women to go out and start taking low-dose aspirin without talking with their prenatal provider about whether they are at high enough risk to begin taking aspirin," he said. "This is not something women should do on their own. This is something they should do in consultation with their health care provider."
The U.S. Preventive Services Task Force is an independent,
volunteer panel of national experts that makes evidence-based
recommendations about preventive medical services such as health
screenings, counseling and medications.
The draft recommendation on aspirin treatment for preeclampsia
has been posted for public comment at
www.uspreventiveservicestaskforce.org. Comments can be submitted
from April 8 to May 5.
Henderson said the new review echoes earlier research and
evidence reviews that have supported low-dose aspirin to prevent
preeclampsia in high-risk mothers.
"It's not a big difference from what's been found earlier," she said.
For more about preeclampsia, visit the
U.S. National Institute of Child Health an...uman
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.